BVF PARTNERS L P/IL

See Remarks at CTI BIOPHARMA CORP · on record since Jun 28, 2023
Former 10% Owner at POINT Biopharma Global Inc. · on record since Dec 20, 2023
10% owner at enGene Therapeutics Inc. · on record since Nov 13, 2023
10% owner at POINT Biopharma Global Inc. · on record since Nov 6, 2023
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Jan 29, 2024
10% owner at Allakos Inc. · on record since Jan 26, 2024
10% owner at Xenon Pharmaceuticals Inc. · on record since Sep 12, 2016
See Explanation of Responses at TF FINANCIAL CORP · on record since Oct 31, 2024
See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since Dec 17, 2024
See Explanation of Responses at 4D Molecular Therapeutics, Inc. · on record since Nov 13, 2024
See Explanation of Responses at Olema Pharmaceuticals, Inc. · on record since Dec 4, 2024
See Explanation of Responses at KENT FINANCIAL SERVICES INC · on record since Dec 28, 2011
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
Director at Rain Oncology Inc. · on record since May 25, 2021
10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 29, 2009
10% owner at ADOLOR CORP · on record since Sep 24, 2009
10% owner at CORVAS INTERNATIONAL INC · on record since Jul 11, 2003
10% owner at · on record since Sep 21, 2009
10% owner at · on record since Jul 16, 2009
10% owner at · on record since Sep 10, 2009
10% owner at · on record since Jul 17, 2003
Indirect Beneficial Owner at · on record since Jul 17, 2003
10% owner at · on record since Dec 24, 2009
10% owner at · on record since Dec 24, 2009
10% owner at · on record since Oct 23, 2009
10% owner at · on record since Oct 23, 2009
Indirect Beneficial Owner at · on record since Jul 22, 2003
10% owner at · on record since Mar 29, 2010
10% owner at · on record since Jul 29, 2003
Indirect Beneficial Owner at · on record since Jul 29, 2003
10% owner at · on record since Apr 21, 2010
10% owner at · on record since Mar 23, 2011
Director at · on record since Apr 2, 2026
10% owner at · on record since Apr 2, 2026
10% owner at · on record since Sep 5, 2003
10% owner at · on record since Jun 29, 2011
10% owner at · on record since Aug 22, 2011
10% owner at · on record since Sep 9, 2011
10% owner at · on record since Dec 5, 2011
10% owner at · on record since Oct 7, 2011
10% owner at · on record since Oct 21, 2003
Indirect Beneficial Owner at · on record since Oct 21, 2003
10% owner at · on record since Oct 29, 2003
Indirect Beneficial Owner at · on record since Oct 29, 2003
See Explanation of Responses at · on record since Feb 10, 2012
Indirect Beneficial Owner at · on record since Nov 7, 2003
10% owner at · on record since Dec 30, 2016
10% owner at · on record since Aug 31, 2012
Indirect Beneficial Owner at · on record since Jan 6, 2004
10% owner at · on record since Jan 6, 2004
10% owner at · on record since May 15, 2013
10% owner at · on record since May 18, 2026
10% owner at · on record since Jun 7, 2013
See Explanation of Responses at · on record since Mar 26, 2014
See Explanation of Responses at · on record since Mar 25, 2014
10% owner at · on record since Feb 10, 2014
10% owner at · on record since Feb 18, 2004
Indirect Beneficial Owner at · on record since Feb 18, 2004
See Explanation of Responses at · on record since Jul 16, 2014
See Explanation of Responses at · on record since Aug 21, 2015
10% owner at · on record since Dec 14, 2015
See Explanation of Responses at · on record since Nov 5, 2015
10% owner at · on record since Jun 22, 2017
10% owner at · on record since Jan 28, 2005
Indirect Beneficial Owner at · on record since Jan 28, 2005
10% owner at · on record since May 11, 2017
10% owner at · on record since Sep 29, 2017
See Explanation of Responses at · on record since Jul 18, 2017
10% owner at · on record since Nov 27, 2017
10% owner at · on record since Dec 8, 2017
10% owner at · on record since Nov 26, 2018
10% owner at · on record since Nov 9, 2018
10% owner at · on record since Jul 1, 2019
10% owner at · on record since Oct 31, 2019
10% owner at · on record since Dec 12, 2019
10% owner at · on record since Jan 21, 2020
10% owner at · on record since Jun 22, 2020
Director at · on record since Aug 25, 2020
10% owner at · on record since Aug 20, 2020
See Explanation of Responses at · on record since Dec 28, 2020
10% owner at · on record since Dec 28, 2020
Director at · on record since Nov 20, 2020
10% owner at · on record since Nov 20, 2020
See Explanaton of Responses at · on record since Nov 20, 2020
See Explanaton of Responses at · on record since Nov 13, 2020
10% owner at · on record since Oct 5, 2020
See Explanation of Responses at · on record since Feb 19, 2021
See Explanation of Responses at · on record since Feb 18, 2021
Director at · on record since Mar 12, 2021
See Explanation of Responses at · on record since Feb 4, 2021
10% owner at · on record since Nov 8, 2021
10% owner at · on record since Jan 10, 2022
10% owner at · on record since Feb 7, 2022
10% owner at · on record since Jun 27, 2022
10% owner at · on record since Jul 21, 2022
10% owner at · on record since Dec 22, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Jan 13, 2023
10% owner at · on record since Feb 13, 2023
See Remarks at · on record since Jan 9, 2023
10% owner at · on record since Oct 5, 2026

Insider trading activity of BVF PARTNERS L P/IL

Transactions on record: 313; since Jul 29, 2003

Open-market buys: 167; $31.4M

Open-market sells: 96; $341.9M

Companies traded: 32; last filing Sep 18, 2026

Figures computed from official regulatory filings — .

Track record of BVF PARTNERS L P/IL

Statistical track record

Free account

Open-market buys: 170

Last buy: May 27, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BVF PARTNERS L P/IL

Co-insiders of BVF PARTNERS L P/IL

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
IMMUNIC, INC.Listing on record	Sep 18, 2026	AwardD (derivative)	25,370	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-2,773,545	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-3,635,758	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-772,000	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-412,000	—	n/a (No price was disclosed in the filing)		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-837,914	106.50 USD	$89.2M	Unusual size	SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-51,858	106.50 USD	$5.5M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-113,289	106.50 USD	$12.1M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-627,597	106.50 USD	$66.8M	Unusual size	SEC
Kymera Therapeutics, Inc.Listing on record	Jun 25, 2026	AwardD (derivative)	6,068	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Olema Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	29,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MoonLake ImmunotherapeuticsListing on record	Jun 22, 2026	AwardD (derivative)	22,195	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	772,000	4.03 USD	$3.1M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	2,313,000	4.03 USD	$9.3M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	1,506,000	4.03 USD	$6.1M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-1,506	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-772	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	412,000	4.03 USD	$1.7M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-2,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-1,569,116	16.79 USD	$26.3M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-1,932,354	16.79 USD	$32.4M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-248,530	16.79 USD	$4.2M	Unusual size	SEC
Repare Therapeutics Inc.Listing unverified	Jan 30, 2026	Other	-5,309,432	—	n/a (No price was disclosed in the filing)		SEC
Repare Therapeutics Inc.Listing unverified	Jan 30, 2026	Other	-4,308,573	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
IMMUNIC, INC.Listing on record	Sep 18, 2026	AwardD (derivative)	25,370	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-2,773,545	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-3,635,758	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-772,000	—	n/a (No price was disclosed in the filing)		SEC
XOMA Royalty CorpSecurity delisted	Jul 16, 2026	Other	-412,000	—	n/a (No price was disclosed in the filing)		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-837,914	106.50 USD	$89.2M	Unusual size	SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-51,858	106.50 USD	$5.5M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-113,289	106.50 USD	$12.1M		SEC
Kymera Therapeutics, Inc.Listing on record	Jun 26, 2026	Sell	-627,597	106.50 USD	$66.8M	Unusual size	SEC
Kymera Therapeutics, Inc.Listing on record	Jun 25, 2026	AwardD (derivative)	6,068	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Olema Pharmaceuticals, Inc.Listing on record	Jun 23, 2026	AwardD (derivative)	29,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MoonLake ImmunotherapeuticsListing on record	Jun 22, 2026	AwardD (derivative)	22,195	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	772,000	4.03 USD	$3.1M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	2,313,000	4.03 USD	$9.3M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	1,506,000	4.03 USD	$6.1M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-1,506	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-772	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	Other	412,000	4.03 USD	$1.7M	Unusual size	SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-2,313	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
XOMA Royalty CorpSecurity delisted	May 18, 2026	OtherD (derivative)	-412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-1,569,116	16.79 USD	$26.3M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-1,932,354	16.79 USD	$32.4M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Apr 2, 2026	Sell	-248,530	16.79 USD	$4.2M	Unusual size	SEC
Repare Therapeutics Inc.Listing unverified	Jan 30, 2026	Other	-5,309,432	—	n/a (No price was disclosed in the filing)		SEC
Repare Therapeutics Inc.Listing unverified	Jan 30, 2026	Other	-4,308,573	—	n/a (No price was disclosed in the filing)		SEC

BVF PARTNERS L P/IL

Insider trading activity of BVF PARTNERS L P/IL

Companies where BVF PARTNERS L P/IL has traded

Track record of BVF PARTNERS L P/IL

Transaction history of BVF PARTNERS L P/IL

Co-insiders of BVF PARTNERS L P/IL

BVF PARTNERS L P/IL

Insider trading activity of BVF PARTNERS L P/IL

Companies where BVF PARTNERS L P/IL has traded

Track record of BVF PARTNERS L P/IL

Transaction history of BVF PARTNERS L P/IL

Co-insiders of BVF PARTNERS L P/IL